Long Chain Fat Emulsion（OO）
- Generic Name
- Long Chain Fat Emulsion（OO）
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
适用于进行肠外营养补充脂肪。
- Associated Conditions
- -
- Associated Therapies
- -
Effect of Increased Free Fatty Acids on Leptin Function
Not Applicable
Completed
- Conditions
- ObesityLeptin Resistance
- Interventions
- First Posted Date
- 2012-01-30
- Last Posted Date
- 2018-05-11
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 26
- Registration Number
- NCT01520454
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders
- First Posted Date
- 2011-06-15
- Last Posted Date
- 2016-06-16
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 41
- Registration Number
- NCT01373918
- Locations
- 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸Saint Louis University, Saint Louis, Missouri, United States
Evaluation of OMEGAVEN 10%® (n-3 EFA Lipid Emulsion) in Home Parenteral Nutrition-associated Liver Disease
Not Applicable
Completed
- Conditions
- Liver Diseases
- Interventions
- First Posted Date
- 2011-01-26
- Last Posted Date
- 2016-03-30
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 31
- Registration Number
- NCT01284049
- Locations
- 🇫🇷
Dr Francisca JOLY, Clichy, Hauts de Seine, France
Omega 3 Fatty Acid Efficiency for Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting
Phase 3
Terminated
- Conditions
- Atrial FibrillationIschemic Heart Disease
- Interventions
- First Posted Date
- 2010-08-04
- Last Posted Date
- 2015-03-24
- Lead Sponsor
- Meshalkin Research Institute of Pathology of Circulation
- Target Recruit Count
- 39
- Registration Number
- NCT01175330
- Locations
- 🇷🇺
State Research Institute of Circulation Patholody, Novosibirsk, Russian Federation
Cholestasis Prevention: Efficacy of IV Fish Oil
Phase 1
Completed
- Conditions
- Parenteral NutritionCholestasis
- Interventions
- First Posted Date
- 2007-08-08
- Last Posted Date
- 2020-12-03
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 19
- Registration Number
- NCT00512629
- Locations
- 🇺🇸
Childrens's Hospital Boston, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath